Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 4Other 2Breast 1

Conditions

Sexual Dysfunction, Physiological 2Prostatic Neoplasms 2Urinary Incontinence 1

Interventions

Radiotherapy 5Surveys and Questionnaires 4Cisplatin 4angiotensin I (1-7) 3alvimopan 3Radiation 3Injections 3Water 2Vitamin D 2Tirzepatide 2RRx-001 2Mouthwashes 2Metformin 2Interleukin 1 Receptor Antagonist Protein 2High-Intensity Focused Ultrasound Ablation 2Drug Therapy 2Dexmedetomidine 2Dexamethasone 2Calcium Dobesilate 2Amifostine 2Acetylcysteine 2tempol 1peppermint oil 1pegfilgrastim 1naloxegol 1methylnaltrexone 1methyl N-acetylsibirosaminide 1linaclotide 1licogliflozin 1kang-lai-te 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × High-Intensity Focused Ultrasound Ablation × Other × Clear all
NCT00561314 2013-08-26

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
33 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

NCT00988130 2013-08-26

High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡